AzTrials
AzTrials

Parastomal HerniaAPOLLONCT06791642

Laparoscopic Parastomal Hernia Repair Using the Sandwich Technique:

An observational study of Parastomal Hernia, run by Azienda Sanitaria Locale Napoli 2 Nord at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study focuses on improving the surgical repair of parastomal hernias (PSHs), which are a common complication for patients with stomas. The investigators are examining the effectiveness of a specific technique called the "sandwich method," which uses two layers of mesh to reinforce the hernia site and reduce… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Parastomal Hernia
What is being tested?
Laparoscopic Parastomal Hernia Repair Using the Sandwich Technique
Type of treatment
Medical device
How many people
31 participants
Where
1 siteItaly
Study dates
1 Jan 2018to 1 Jan 2025
How long will I take part?
24 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will consist of adult patients with a diagnosed parastomal hernia who are referred for surgical repair at participating hospitals. These patients are representative of individuals commonly managed in general and colorectal surgery practices, and they will be selected from both inpatient and outpatient settings.

Who may be able to join

  • Specify the criteria for participating in the study in a bulleted list under each category heading ("Inclusion Criteria" and "Exclusion Criteria"). Include only one item per bullet.

Who cannot join

  • Age below 18 years.
  • Patients with recurrent parastomal hernia repairs requiring an open surgical approach.
  • Evidence of active abdominal infection or sepsis at the time of surgery.
  • Known allergies to mesh materials used in the study (e.g., Parietex™ or Synecor™).
  • Presence of significant comorbidities making laparoscopic surgery unsafe (e.g., advanced cardiopulmonary disease).
  • Pregnancy at the time of surgery.
  • Inability to provide informed consent or comply with follow-up requirements.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • francesco Pizza

    Naples, Italy, 80131

Other trials in Italy

About this study

Official title: Laparoscopic Parastomal Hernia Repair Using the Sandwich Technique: A Multicenter Study of Clinical Outcomes, Recurrence Rates, and Quality of Life Improvements

This study focuses on improving the surgical repair of parastomal hernias (PSHs), which are a common complication for patients with stomas. The investigators are examining the effectiveness of a specific technique called the "sandwich method," which uses two layers of mesh to reinforce the hernia site and reduce recurrence. The objective is to evaluate how well this method works over time, assess its impact on patient recovery and quality of life, and compare outcomes for different types of surgical materials used. This research aims to provide clearer guidance for surgeons and improve long-term results for patients undergoing PSH repair.

Read the detailed description

Study Description: Improving Surgical Outcomes for Parastomal Hernia Repair

Parastomal hernias (PSHs) are a common and challenging complication that occurs in patients with stomas-surgically created openings in the abdomen used to divert waste. These hernias can cause discomfort, limit daily activities, and require surgical intervention to repair. Despite advancements in surgical techniques, PSH repair remains a complex issue, with high recurrence rates and varying outcomes.

This study investigates the effectiveness of a specific surgical approach called the "sandwich technique" for PSH repair. This method uses two layers of mesh to reinforce the abdominal wall and provide extra support around the stoma, aiming to reduce the likelihood of hernia recurrence while maintaining the function of the stoma. The first layer of mesh is placed directly around the stoma in a "keyhole" fashion, and the second layer reinforces the surrounding abdominal wall in a broader "overlay" configuration.

The research evaluates multiple aspects of this technique:

  1. Effectiveness: Measuring recurrence rates over time, particularly for patients with larger hernias or recurrent hernias.
  2. Safety: Assessing complications such as infections, seromas (fluid accumulation), or mesh-related issues.
  3. Quality of Life (QoL): Using patient-reported surveys to evaluate how the repair impacts physical comfort, stoma care, body image, and social activities.
  4. Comparison of Materials: Analyzing outcomes for two commonly used mesh types-Parietex™ Composite Mesh and Synecor™ Hybrid Mesh-to determine if material selection affects long-term results.

The study incorporates the European Hernia Society (EHS) classification system to categorize hernia types based on size and complexity. This allows for a tailored approach to treatment and helps identify which patients may benefit most from specific surgical strategies.

While the sandwich technique has shown promise in reducing recurrence rates and enhancing recovery, this research seeks to provide stronger evidence to guide surgeons in selecting the best techniques and materials for PSH repair. By focusing on patient-centered outcomes and refining surgical methods, the study aims to improve long-term results and overall quality of life for individuals living with stomas.

Being tested
Laparoscopic Parastomal Hernia Repair Using the Sandwich Technique
Keywords
stoma, hernia, Laparoscopic repair
Medical subject headings
Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic Parastomal Hernia Repair Using the Sandwich TechniqueDevice

    The sandwich technique was performed laparoscopically according to minimally invasive principles. Pneumoperitoneum was typically established using a Veress needle if the subcostal region was free from previous surgical scarring. For patients with prior extensive abdominal surgeries, a small laparotomy was performed to place the first 10-mm trocar directly under vision, ensuring safe entry into the peritoneal cavity. A 30° laparoscope was used throughout the procedure for enhanced visualization of the operative field.

    Trocar placement was designed to optimize access and ergonomics. The primary trocar was placed either in the periumbilical region or in the left or right flank, depending on the patient's anatomy and stoma location. Mesh used:1. Parietex™ Composite Mesh (Medtronic, USA): A multifilament polyester mesh with an anti-adhesive collagen barrier to minimize visceral adhesions.

  • Laparoscopic Parastomal Hernia Repair Using the Sandwich TechniqueDevice

    The sandwich technique was performed laparoscopically according to minimally invasive principles. Pneumoperitoneum was typically established using a Veress needle if the subcostal region was free from previous surgical scarring. For patients with prior extensive abdominal surgeries, a small laparotomy was performed to place the first 10-mm trocar directly under vision, ensuring safe entry into the peritoneal cavity. A 30° laparoscope was used throughout the procedure for enhanced visualization of the operative field.

    Trocar placement was designed to optimize access and ergonomics. The primary trocar was placed either in the periumbilical region or in the left or right flank, depending on the patient's anatomy and stoma location. Mesh use Synecor™ Hybrid Mesh (BD, USA): A macroporous mesh combining polypropylene with a bioresorbable layer that degrades over time, leaving a durable support structure to promote tissue integration.

Study groups in NCT06791642
Study groupRoleWhat they receive
Group 1: Parietex™ Composite MeshGroup 1: Parietex™ Composite Mesh This group consisted of patients who had their PSH repair performed using the Parietex™ Composite Mesh, a dual-layer synthetic mesh designed to promote tissue integration while minimizing the risk of adhesions. The Parietex™ mesh is composed of a macroporous structure on one side, which facilitates tissue ingrowth, and an anti-adhesive barrier on the other side to reduce complications such as bowel adhesions or erosion. This mesh was applied using the sandwich technique, combining a keyhole configuration around the stoma with an overlay reinforcement of the abdominal wall.
Receives: Device: Laparoscopic Parastomal Hernia Repair Using the Sandwich Technique
Group 2: Synecor™ Hybrid MeshThis group included patients who underwent PSH repair using the Synecor™ Hybrid Mesh, an advanced composite mesh that combines biologic and synthetic materials. The Synecor™ mesh integrates a bioresorbable layer for improved biocompatibility and tissue integration with a synthetic layer to enhance long-term strength and durability. It also incorporates anti-adhesive properties to minimize the risk of complications. Similar to the Parietex™ group, this mesh was used in the sandwich technique to provide dual-layer reinforcement. Key features of this group: * Mesh composition: Hybrid with bioresorbable and synthetic components for strength and tissue integration. * Clinical outcomes assessed: Recurrence rates, SSIs, seromas, and mesh-related complications, including hematomas or bulging.
Receives: Device: Laparoscopic Parastomal Hernia Repair Using the Sandwich Technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. hernia recurrence rate

    defined as clinical or radiological confirmation of a recurrent parastomal hernia.

    Measured: 12 months

  2. hernia recurrence rate

    defined as clinical or radiological confirmation of a recurrent parastomal hernia.

    Measured: 24 months

Secondary outcomes (19)
  1. Surgical Site Infections (SSIs)

    The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity. SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.

    Measured: 1 months

  2. Surgical Site Infections (SSIs)

    The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity. SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.

    Measured: 3 months

  3. Surgical Site Infections (SSIs)

    The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity. SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.

    Measured: 6 months

  4. Surgical Site Infections (SSIs)

    The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity. SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.

    Measured: 12 months

  5. Surgical Site Infections (SSIs)

    The occurrence of surgical site infections was assessed as a critical indicator of postoperative morbidity. SSIs were monitored through clinical evaluations, including signs of redness, swelling, warmth, pain, and discharge at the surgical site, and were managed according to established guidelines.

    Measured: 24 months

  6. Number of Participants with Postoperative Seroma Formation

    Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.

    Measured: 1 months

  7. Number of Participants with Postoperative Seroma Formation:

    Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.

    Measured: 3 months

  8. Number of Participants with Postoperative Seroma Formation:

    Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.

    Measured: 6 months

  9. Number of Participants with Postoperative Seroma Formation:

    Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.

    Measured: 12 months

  10. Number of Participants with Postoperative Seroma Formation:

    Accumulation of fluid at the surgical site, confirmed through physical examination or imaging.

    Measured: 24 months

  11. Number of Participants with Postoperative Hematoma Formation

    Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.

    Measured: 1 months

  12. Number of Participants with Postoperative Hematoma Formation

    Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.

    Measured: 3 months

  13. Number of Participants with Postoperative Hematoma Formation

    Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.

    Measured: 6 months

  14. Number of Participants with Postoperative Hematoma Formation

    Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.

    Measured: 12 months

  15. Number of Participants with Postoperative Hematoma Formation

    Localized blood collection near the surgical site, evaluated clinically or with imaging as needed.

    Measured: 24 months

  16. Mesh-Related Complications:Bowel Adhesions

    Abnormal fibrous connections between the bowel and mesh, potentially causing pain or obstruction.

    Measured: until 24 months

  17. Mesh-specific complications : Mesh Migration:

    Displacement of the mesh from its intended position.

    Measured: until 24 month

  18. Mesh-Related Complications:Mesh Erosion into the Stoma

    Displacement of the mesh from its intended position.

    Measured: until 24 months

  19. Number of Participants with Postoperative Bowel Obstruction

    Episodes of bowel obstruction were recorded based on patient symptoms (e.g., abdominal distension, vomiting) and confirmed using imaging studies

    Measured: until 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2025
  2. Study start1 Jan 2018
  3. Primary completion31 Dec 2022
  4. Study completion1 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
31 participants (actual)
Target duration
24 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT06791642
Sponsor's protocol ID
20252819
Acronym
APOLLO
Status last verified
Jan 2025
First submitted
19 Jan 2025
Last updated
27 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided: Explanation for Not Sharing Individual Participant Data (IPD) Individual participant data (IPD) will not be shared due to the following considerations: 1. Patient Confidentiality: Sharing IPD may risk breaching participant privacy, even if anonymized, particularly given the detailed nature of surgical and clinical data. 2. Ethical Constraints: The consent obtained from participants does not include provisions for data sharing beyond the scope of this study. 3. Regulatory Compliance: Institutional policies and local regulations may limit the sharing of sensitive health information. 4. Data Ownership: The data is collected across multiple centers, and permissions for sharing may vary depending on institutional agreements and data governance policies. 5. Limited Generalizability of Raw Data: Given the study's small sample size and highly specialized focus, the broader utility of the raw IPD for external analysis is limited.

Publications

  • Antoniou SA, Agresta F, Garcia Alamino JM, Berger D, Berrevoet F, Brandsma HT, Bury K, Conze J, Cuccurullo D, Dietz UA, Fortelny RH, Frei-Lanter C, Hansson B, Helgstrand F, Hotouras A, Janes A, Kroese LF, Lambrecht JR, Kyle-Leinhase I, Lopez-Cano M, Maggiori L, Mandala V, Miserez M, Montgomery A, Morales-Conde S, Prudhomme M, Rautio T, Smart N, Smietanski M, Szczepkowski M, Stabilini C, Muysoms FE. European Hernia Society guidelines on prevention and treatment of parastomal hernias. Hernia. 2018 Feb;22(1):183-198. doi: 10.1007/s10029-017-1697-5. Epub 2017 Nov 13.

    PubMed 29134456

Questions about this trial

What is this clinical trial studying?

An observational study of Parastomal Hernia, run by Azienda Sanitaria Locale Napoli 2 Nord at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

hernia recurrence rate (time frame: 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06791642, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in